Serina Therapeutics, Inc. financial data

Symbol
SER on NYSE
Industry
Pharmaceutical Preparations
Location
601 Genome Way, Suite 2001, Huntsville, AL
State of incorporation
AL
Fiscal year end
December 31
Former names
AgeX Therapeutics, Inc. (to 4/1/2024)
Latest financial report
10-Q - Q3 2024 - Nov 12, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 74.2 % +569%
Debt-to-equity -102 % -38.3%
Return On Equity 96.1 %
Return On Assets -230 % -1629%
Operating Margin -12.3K % -77.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 8.89M shares -76.6%
Common Stock, Shares, Outstanding 8.89M shares -76.6%
Entity Public Float 18.7M USD +54.5%
Common Stock, Value, Issued 1K USD -75%
Weighted Average Number of Shares Outstanding, Basic 8.85M shares +304%
Weighted Average Number of Shares Outstanding, Diluted 10.8M shares +41.8%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 146K USD +97.3%
Cost of Revenue 40K USD +208%
Research and Development Expense 4.37M USD +159%
General and Administrative Expense 13.8M USD +291%
Operating Income (Loss) -18M USD -250%
Nonoperating Income (Expense) -3.89M USD -159%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 10.5M USD +20.7%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -21.8M USD -1542%
Earnings Per Share, Basic -20.3 USD/shares -168%
Earnings Per Share, Diluted -19 USD/shares -43.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 3.19M USD +702%
Accounts Receivable, after Allowance for Credit Loss, Current 65K USD +983%
Other Assets, Current 143K USD
Assets, Current 5.42M USD +375%
Property, Plant and Equipment, Net 519K USD
Operating Lease, Right-of-Use Asset 509K USD
Intangible Assets, Net (Excluding Goodwill) 509K USD -20.5%
Assets 7.44M USD -39.1%
Accounts Payable, Current 1.2M USD +138%
Accrued Liabilities, Current 1.16M USD +296%
Liabilities, Current 13.5M USD +322%
Operating Lease, Liability, Noncurrent 312K USD
Liabilities 21.3M USD +446%
Retained Earnings (Accumulated Deficit) -21.8M USD +82.9%
Stockholders' Equity Attributable to Parent -13.8M USD +50%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -13.8M USD +58.5%
Liabilities and Equity 7.44M USD -39.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.58M USD -122%
Net Cash Provided by (Used in) Financing Activities 2.73M USD -73%
Net Cash Provided by (Used in) Investing Activities -14K USD +99.9%
Common Stock, Shares Authorized 40M shares -80%
Common Stock, Shares, Issued 8.89M shares -76.6%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 1.14M USD -87.9%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1K USD -92.9%
Deferred Tax Assets, Valuation Allowance 20.8M USD +12.8%
Operating Lease, Liability 509K USD
Depreciation 24K USD +33.3%
Payments to Acquire Property, Plant, and Equipment 14K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -11.1M USD -19.4%
Lessee, Operating Lease, Liability, to be Paid 559K USD
Property, Plant and Equipment, Gross 980K USD
Operating Lease, Liability, Current 197K USD
Lessee, Operating Lease, Liability, to be Paid, Year Two 159K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 217K USD
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 50K USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 117K USD
Deferred Tax Assets, Operating Loss Carryforwards 14.3M USD +15.1%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 393K USD +3.69%
Operating Lease, Payments 55K USD +25%
Additional Paid in Capital 8M USD -92%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 101K USD -22.9%
Share-based Payment Arrangement, Expense 2.23M USD +1517%
Interest Expense 4.91M USD +72.4%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%